ICLR Stock Price Today (October 2026) — ICON Public Limited Company Analysis & Key Metrics 2026-10-20
ICON Public Limited Company (ICLR) is trading at $174.19, up 3.60% today (as of October 2026). The stock continues to show sustained strength above key moving averages, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $187.76 (7.8% upside).
- Volatility is moderate (36.32% annualized), implying notable price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: steady revenue (1.20% YoY) alongside competitive pressures in the Diagnostics & Research space.
ICLR Stock Analysis: Key Metrics & Valuation (October 2026)
Concise, actionable data for investors
ICON Public Limited Company - Historical Price & Volume
- Price
- Volume
- Latest price
Market Cap
Enterprise Value: $16.04B
P/E Ratio
Forward P/E: 14.80
Revenue Growth
Year over Year
Analyst Target
+7.8% upside potential
Key Investor Questions About ICLR
What investors need to know before buying
Based on current market data, ICLR presents a neutral technical setup with mixed signals fundamentals.
- Technicals say: Neutral (RSI 59.71)
- Fundamentals say: Mixed signals (nuanced financial profile)
ICLR's growth trajectory depends on its ability to expand within the Diagnostics & Research sector while managing margin pressures.
- Future growth will depend on performance in core Diagnostics & Research operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for ICLR investors include debt exposure and competitive dynamics in the Diagnostics & Research industry.
- $3.53B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Diagnostics & Research.
52-Week Trading Range
Over the past year, ICLR stock traded between $66.57 and $203.91 and currently trades in the middle of that range. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 36.32% annualized volatility and β=1.27, the stock exhibits high sensitivity to market moves—making ICLR suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
Moderate ownership metrics suggest a balanced supply-demand dynamic.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines, coverage and TickZen analysis
Market news
Icon's 2027 Outlook Supported by Strong Bookings as Growth Questions Persist, RBC Says
ICON Schedules Third Quarter 2026 Earnings Conference Call
UBS Downgrades ICON to Neutral From Buy
ICON Public Limited Company’s (ICLR) Shrinking Moat Warranted an Early Departure
Icon Insider Sold Shares Worth $875,875, According to a Recent SEC Filing
Latest TickZen Insights
All insights →No TickZen article on ICLR yet. Our newest analysis:
Explore More Analysis for ICLR
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Earnings snapshot
Next report Oct 27, 2026 (after the close)
Frequently Asked Questions
Common investor questions about ICON Public Limited Company
ICON Public Limited Company (ICLR) is currently trading at $174.19. The RSI (14-day) is at 59.7, indicating neutral territory. Wall Street analysts have a consensus "buy" recommendation. The mean analyst price target of $187.76 implies 7.8% upside from current levels. Volatility is moderate at 36.3% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for ICON Public Limited Company (ICLR): The trailing P/E ratio is 183.36, which is above the market average, indicating investors are pricing in higher growth expectations. The forward P/E is 14.80, lower than the trailing P/E, suggesting analysts expect earnings improvement. Price-to-Book is 1.43. Price-to-Sales is 1.62. Valuation should be compared to Diagnostics & Research industry peers for context, as different sectors trade at different multiples.
Based on 17 analysts covering ICLR, the consensus price target is $187.76. This represents a 7.8% upside from the current price of $174.19. The range spans from a low target of $155.00 to a high target of $220.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
ICON Public Limited Company (ICLR) does not currently pay a regular dividend. The company may be reinvesting profits into growth initiatives, or may not yet be profitable enough to distribute earnings to shareholders.
Key risks for ICON Public Limited Company (ICLR) investors include: 1. Moderate volatility (36.3% annualized)—price swings are notable. 2. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 3. Diagnostics & Research sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is ICON Public Limited Company's (ICLR) current debt and financial health profile: Total debt stands at $3.53B. The debt-to-equity ratio is 0.38x, which is moderate and generally manageable for most companies. The current ratio is 0.95, which is below 1.0 and may indicate short-term liquidity concerns. The quick ratio is 0.92. The company holds $928.39M in cash and equivalents. Free cash flow is positive at $883.82M, providing a cushion for debt servicing and shareholder returns.